. Author manuscript; available in PMC: 2012 Aug 3.

Published in final edited form as: Cell Metab. 2011 Aug 3;14(2):208–218. doi: 10.1016/j.cmet.2011.06.007

Table 1.

Clinical characteristics of study subjects. Subjects had no known abnormality in glucose metabolism prior to study. Six obese subjects were diagnosed with type 2 diabetes (T2D) during the liver study. Four obese subjects were diagnosed with impaired glucose tolerance (IGT) and three with T2D during the muscle study. Data are mean ± SD.

	Liver study		Skeletal muscle study

	Lean NGT	Obese NGT/T2D	Lean NGT	Obese IGT/T2D
Men / Women	0 / 5	2 / 6	0 / 10	0 / 7
Age (years)	36 ± 12	43 ± 11	59.6 ± 5.0	60.0 ± 4.8
Body Mass Index (kg/m²)	24 ± 5	53 ± 7^**	27.4 ± 5.4	31.8 ± 6.5^*
Fasting glucose (mmol/L)	4.8 ± 0.8	6.5 ± 2.0	4.5 ± 0.6	5.0 ± 0.8
Fasting insulin (pmol/L)	36.8 ± 33.0	148.2 ± 132.6^*	40.3 ± 20.2	73.0 ± 23.4^*

p<0.05,

^**

p<0.001 vs. lean of the same study.